Get the Stockscreener App
2.76
0.36%
-0.01
After Hours:
2.76
Calcimedica Inc Stock (CALC) Forecast
The Calcimedica Inc (CALC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $10.15, representing a +267.73% increase from the current price of $2.76. The highest analyst price target is $11.35, and the lowest is $8.95.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CALC Price Target
Average 12.66
(+358.64% Upside)
Is Calcimedica Inc (CALC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.02 | Neutral |
| STOCH(9,6) | 56.08 | Neutral |
| STOCHRSI(14) | 93.30 | Sell |
| MACD(12,26) | -0.2188 | Buy |
| ADX(14) | 40.88 | Sell |
| William %R | -49.65 | Neutral |
| CCI(14) | -10.01 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.778
Sell
|
2.8254
Sell
|
| MA20 |
3.0245
Sell
|
2.9836
Sell
|
| MA50 |
3.458
Sell
|
3.3723
Sell
|
| MA100 |
3.9108
Sell
|
3.7406
Sell
|
| MA200 |
4.3271
Sell
|
3.894
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CALC could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on CALC, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.02 indicates that CALC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 56.08 indicates that CALC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 93.3 indicates that CALC is oversold. This suggests that CALC price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 40.88 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -10.01 indicates that CALC is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CALC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Calcimedica Inc financial reports and earnings history, Calcimedica Inc (CALC) stock could reach $36.45 by 2030, $90.99 by 2040 and $151.99 by 2050. See the projected annual prices until 2050 of the Calcimedica Inc stock below:
- Calcimedica Inc (CALC) is expected to reach an average price of $45.86 in 2035, with a high prediction of $81.82 and a low estimate of $45.79. This indicates an $1,562% rise from the last recorded price of $2.76.
- Calcimedica Inc (CALC) stock is projected to chart a bullish course in 2040, with an average price target of $90.68, representing an $3,186% surge from its current level. The forecast ranges from a conservative $86.06 to a sky-high $90.99.
- Our analysts predict Calcimedica Inc (CALC) to jump 2,973% by 2045, soaring from $82.84 to an average price of $84.83, potentially reaching $151.97. While $82.84 is the low estimate, the potential upside is significant.
- Calcimedica Inc (CALC) stock is expected to climb by 2050, reaching an average of $151.31, a $5,382% jump from its current level. However, a wide range of estimates exists, with high and low targets of $151.99 and $141.94, respectively, highlighting the market's uncertainty.
Calcimedica Inc Stock (CALC) Year by Year Forecast
Calcimedica Inc Stock (CALC) Price Forecast for 2025
Calcimedica Inc Stock (CALC) is expected to reach an average price of $12.66 in 2025, with a high prediction of $17.08 and a low estimate of $8.2335. This indicates an +358.64% rise from the last recorded price of $2.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $11.06 | $8.95 | $11.35 | +300.77% |
| February, 2025 | $8.6012 | $8.5212 | $11.66 | +211.64% |
| March, 2025 | $8.3535 | $8.2335 | $9.1617 | +202.66% |
| April, 2025 | $10.62 | $8.3641 | $10.97 | +284.65% |
| May, 2025 | $11.55 | $10.10 | $11.96 | +318.43% |
| June, 2025 | $11.76 | $10.65 | $11.91 | +326.13% |
| July, 2025 | $14.41 | $11.51 | $17.08 | +422.25% |
| August, 2025 | $13.74 | $13.40 | $14.98 | +397.70% |
| September, 2025 | $14.00 | $13.19 | $14.54 | +407.20% |
| October, 2025 | $15.98 | $13.88 | $16.33 | +479.05% |
| November, 2025 | $11.95 | $11.59 | $17.06 | +332.82% |
| December, 2025 | $11.60 | $11.48 | $12.21 | +320.12% |
Calcimedica Inc Stock (CALC) Price Forecast for 2026
The predicted value for Calcimedica Inc (CALC) in 2026 is set at an average of $17.06. Estimates vary from a peak of $22.45 to a trough of $11.67, indicating an +518.22% surge from the present price of $2.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $13.88 | $11.67 | $14.47 | +402.99% |
| February, 2026 | $15.22 | $13.73 | $15.66 | +451.54% |
| March, 2026 | $14.94 | $14.54 | $15.38 | +441.15% |
| April, 2026 | $20.50 | $15.13 | $21.44 | +642.58% |
| May, 2026 | $18.33 | $17.94 | $21.01 | +564.09% |
| June, 2026 | $18.56 | $18.33 | $19.41 | +572.55% |
| July, 2026 | $19.62 | $18.13 | $20.15 | +610.93% |
| August, 2026 | $14.51 | $14.44 | $22.45 | +425.72% |
| September, 2026 | $14.81 | $14.48 | $15.25 | +436.45% |
| October, 2026 | $16.60 | $14.72 | $16.61 | +501.47% |
| November, 2026 | $18.95 | $16.98 | $19.36 | +586.42% |
| December, 2026 | $18.96 | $18.38 | $19.36 | +587.00% |
Calcimedica Inc Stock (CALC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Calcimedica Inc (CALC) is $23.71, with a high forecast of $30.14 and a low forecast of $17.29. This indicates an +759.22% increase from the last price of $2.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $22.72 | $19.22 | $23.40 | +723.04% |
| February, 2027 | $22.68 | $22.49 | $25.79 | +721.76% |
| March, 2027 | $23.44 | $22.72 | $24.29 | +749.14% |
| April, 2027 | $24.98 | $23.07 | $25.13 | +805.11% |
| May, 2027 | $26.33 | $24.81 | $27.85 | +854.04% |
| June, 2027 | $17.87 | $17.29 | $18.30 | +547.31% |
| July, 2027 | $19.06 | $17.83 | $19.20 | +590.64% |
| August, 2027 | $21.53 | $19.33 | $21.66 | +680.24% |
| September, 2027 | $22.85 | $21.84 | $23.18 | +727.90% |
| October, 2027 | $25.89 | $22.81 | $25.94 | +837.93% |
| November, 2027 | $28.21 | $26.25 | $30.14 | +922.16% |
| December, 2027 | $28.54 | $27.04 | $28.81 | +934.20% |
Calcimedica Inc Stock (CALC) Price Forecast for 2028
In 2028, Calcimedica Inc (CALC) is projected to reach an average price of $29.39, with a high projection of $38.64 and a low estimate of $20.14. This indicates an +964.92% rise from the last price of $2.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $29.65 | $28.01 | $29.89 | +974.10% |
| February, 2028 | $32.39 | $29.98 | $32.67 | +1,073% |
| March, 2028 | $20.93 | $20.14 | $33.25 | +658.51% |
| April, 2028 | $22.07 | $20.92 | $22.13 | +699.72% |
| May, 2028 | $25.17 | $22.43 | $25.29 | +811.88% |
| June, 2028 | $26.45 | $25.54 | $27.00 | +858.27% |
| July, 2028 | $28.35 | $26.66 | $28.66 | +927.00% |
| August, 2028 | $32.69 | $28.68 | $34.49 | +1,085% |
| September, 2028 | $32.93 | $31.59 | $33.17 | +1,093% |
| October, 2028 | $34.19 | $32.95 | $34.43 | +1,139% |
| November, 2028 | $37.72 | $34.30 | $38.00 | +1,267% |
| December, 2028 | $23.50 | $22.99 | $38.64 | +751.60% |
Calcimedica Inc Stock (CALC) Price Forecast for 2029
The 2029 price forecast for Calcimedica Inc Stock (CALC) is $33.95 on average, with a high prediction of $44.04 and a low estimate of $23.86. This represents an +1,130% increase from the previous price of $2.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $25.38 | $23.86 | $25.44 | +819.54% |
| February, 2029 | $28.46 | $25.81 | $28.70 | +931.07% |
| March, 2029 | $30.70 | $28.26 | $30.70 | +1,012% |
| April, 2029 | $32.21 | $30.12 | $32.36 | +1,067% |
| May, 2029 | $36.50 | $32.29 | $38.84 | +1,222% |
| June, 2029 | $37.13 | $36.13 | $37.71 | +1,245% |
| July, 2029 | $38.70 | $37.60 | $38.91 | +1,302% |
| August, 2029 | $42.31 | $38.90 | $42.66 | +1,433% |
| September, 2029 | $26.52 | $25.84 | $44.04 | +860.95% |
| October, 2029 | $27.80 | $26.40 | $28.30 | +907.39% |
| November, 2029 | $31.40 | $28.21 | $31.98 | +1,038% |
| December, 2029 | $34.04 | $31.71 | $34.30 | +1,133% |
Calcimedica Inc Stock (CALC) Price Forecast for 2030
Calcimedica Inc Stock (CALC) is expected to reach an average price of $39.06 in 2030, with a high forecast of $49.44 and a low forecast of $28.69. This signifies an +1,315% surge from the last price of $2.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $36.30 | $33.70 | $36.45 | +1,215% |
| February, 2030 | $42.25 | $36.45 | $43.19 | +1,431% |
| March, 2030 | $41.39 | $40.19 | $43.10 | +1,400% |
| April, 2030 | $42.93 | $41.73 | $43.78 | +1,456% |
| May, 2030 | $45.62 | $42.83 | $46.15 | +1,553% |
| June, 2030 | $28.76 | $28.69 | $49.44 | +942.03% |
| July, 2030 | $30.69 | $29.31 | $31.10 | +1,012% |
| August, 2030 | $33.79 | $30.93 | $33.79 | +1,124% |
| September, 2030 | $37.44 | $34.49 | $37.85 | +1,256% |
| October, 2030 | $39.09 | $37.53 | $39.49 | +1,316% |
| November, 2030 | $44.15 | $39.68 | $44.83 | +1,500% |
| December, 2030 | $45.42 | $44.60 | $47.55 | +1,546% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):